Biguanide compositions and methods of treating metabolic disorders
US11065215B2 · kind B2 · utility
2Cited by
48References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2018 |
| Grant date | Jul 20, 2021 |
| Priority date | — |
| Expiry date | Dec 17, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.